HELSINKI, Finland, July 2021. Finnish bioinformatics software company Euformatics, which develops and sells world-leading NGS interpretation and quality control tools, has signed a distribution agreement with Indonesian Illumina distributor PT Pandu Biosains.

Announcement of the agreement brings Euformatics expanded reach into the Southeast Asian market, and makes good on its push to target the region as part of its renewed 2021 strategy. The agreement covers the full omnomics Suite of products from Euformatics, and provides PT Pandu Biosains, the official Illumina distributor in the territory with the capability to offer a true end-to-end solution to their customers by including best-in-class quality control software (omnomicsQ) as well as a comprehensive variant interpretation and reporting tool (omnomicsNGS).

With a focus on delivering the best solutions specifically to customers working on genomics, PT Pandu Biosains is very well placed to add the Euformatics offering to its portfolio and bring the products to the ever-growing Illumina installed base in Indonesia. As is the case with uptake of NGS around the world, the market for the technology in Indonesia is growing at an exponential rate, with more private laboratories opening and making use of the technique. Home to the Eijkman Institute for Molecular Biology in Jakarta, Indonesia already has a history of NGS research that will no doubt help to influence the clinical usage of the technology too.

Fajar Budiman profíle

“We are really impressed with the software offering from Euformatics and believe that it will be of great value to our customers. omnomicsNGS brings together all the information that a clinician needs into one easy-to-use tool making the analysis process much quicker. With the NGS market growing in Indonesia, it is also really important that the data produced is high quality from the start; with omnomicsQ, our customers can be sure of the quality of their data and ensure that it remains consistent over time. With this kind of combined offering we believe that NGS users in Indonesia now have access to one of the best offerings currently available”, says Fajar Reza Budiman, PT Pandu Biosains CEO.

Euformatics CEO Tommi Kaasalainen

Euformatics CEO, Tommi Kaasalainen, explained that “We concluded late last year that Southeast Asia was a target region for us this year and we are really happy to be making that goal a reality through this partnership with PT Pandu Biosains. As the lllumina distributor for Indonesia, they already have the contacts and relationships with the right people, and we have been impressed with the knowledge and skill of the team. We are excited to work together with the team to ensure the success of partnership in the future and play our part in making NGS a mainstream diagnostics technology in Indonesia. This partnership with PT Pandu Biosains complements nicely our current installed base of customers in the region”.

The agreement is the latest on a growing list of distribution and sales channel partner agreements that Euformatics has signed since the beginning of 2021, covering Latin America, Europe and the Middle East. The company has plans to expand significantly in the coming years, starting with building a strong network of international distributor partners.

About PT Pandu Biosains:

Pandu Biosains is an Indonesia-based distributor company for biotechnology instruments with the vision to be leading in providing molecular biology tools and services. Our company provides advance molecular lab equipments and solutions from Illumina, 10x Genomics, Beckman Coulter Life Sciences, ArcherDx, CareDx, Verogen, Shimadzu Life Sciences, IDT, and Major Science. Our products support molecular biology research and diagnostic in wide breadth of area including oncology, RGH, infectious disease, forensics, microbiology, genetic disease, agriculture, molecular and cell biology, forensics, immunology and many more to assist the needs of laboratory equipments in universities, hospitals, clinical company, service provider, research institutions, and other industry. Our company is committed to provide effective and efficient support for both presales and after sales activity.

For more information, please visit our website www.biosains.com

About Euformatics:

Euformatics is a Finnish software company that specialises in high standard bioinformatics tools for genomic data interpretation. Since 2010, Euformatics has been helping medical doctors and molecular genetics laboratories provide better precision medicine for cancer, common or rare disease diagnostics. At present, our core solution is the omnomics Suite which includes omnomicsNGS; for clinical analysis and reporting of patient NGS data, and omnomicsQ; for NGS data quality management.

For more information, please visit our website www.euformatics.com

Press relations:

Jamie McDonald
Euformatics
jamie.mcdonald@euformatics.com

Sonia Meta Angraini
PT Pandu Biosains
meta@biosains.com

Footer liftup

Back to news listing